Oncolytics Biotech Inc ONCY

Panc Phase 3

[lonc17]

How very discouraging, though not at all a surprise coming from this POS company. 

Onc has gone from phase 3 panc trial to registration enabling panc trial to registrational enabling panc trial hopefully sometime this year to BARELY EVEN MENTIONING IT AT ALL ON A CONFERENCE CALL UPDATE. 

https://oncolyticsbiotech.com/wp-content/uploads/2024/04/Oncolytics_Deck-April-v3.pdf

It's no wonder that MC chose to let his options (in the money!) expire this past December. 

Note that my last comment is speculative and based on MC's tardiness complying with SEDI regulations as he has not yet (to my knowledge) recorded any transaction for these expiring options.

[lonc17]

From their news release today: Where's the Panc Registation Enabling Trial?? Anticipated Milestones Mid 2024: Guidance on the registration path for HR+/HER2- mBC (metastatic breast cancer) Q2 2024: Initiation of the GOBLET PDAC cohort investigating pelareorep/mFOLFIRINOX +/- atezolizumab and supported by PanCAN H2 2024: Overall survival results from the BRACELET-1 trial

[lonc17]

This is pretty much the only thing they said in the entire call with regards to Panc Registrational Trial: From Thomas H.  Updating us on an update. This compmay gets worse every day. It's not a scam but damn close, IMO. They do anything and everything they can to secure next quarter's paychecks.  In closing I'd like to discuss our registrational plans for pela in

[Peladawn]

How very VERY discouraging.....more fake news coming from the scumbags trying to short this stock....a total line of bs with no proof whatsoever